Successful MitraClip® implantation after angioplasty of a chronic inferior vena cava filter thrombosis

Barbin, Clay M.; Grayburn, Paul A.; Choi, James W.

doi:10.1002/ccd.25995

Cited by 4 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Soon after, many reported the safety and feasibility of transfemoral structural heart interventions across IVCFs including septal occluder device placement, transcatheter percutaneous balloon mitral valvuloplasty, atrial septostomy, and percutaneous mitral clip placement. 27,28,[44][45][46] Similarly, many EP procedures have been successfully performed across a range of IVCFs including percutaneous defibrillator lead extraction, cavotricuspid isthmus ablations, leadless pacemaker implantation, and pulmonary vein isolation. 41,[47][48][49][50][51][52][53][54] In each of these interventions, authors advocate using direct fluoroscopic guidance when traversing the IVCF and most used preprocedural CT scans or venograms to ensure filter patency.…”

Section: Discussionmentioning

confidence: 99%

Navigating inferior vena cava filters in invasive cardiology procedures: A systematic review

Shah

Patel

Hanson

et al. 2021

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Background: Transfemoral venous access (TFV) is the cornerstone of minimally invasive cardiac procedures. Although the presence of inferior vena cava filters (IVCFs) was considered a relative contraindication to TFV procedures, small experiences have suggested safety. We conducted a systematic review of the available literature on cardiac procedural success of TFV with IVCF in-situ.Methods: Two independent reviewers searched PubMed, EMBASE, SCOPUS, and Google Scholar from inception to October 2020 for studies that reported outcomes in patients with IVCFs undergoing TFV for invasive cardiac procedures. We investigated a primary outcome of acute procedural success and reviewed the pooled data for patient demographics, procedural complications, types of IVCF, IVCF dwell time, and procedural specifics.Results: Out of the 120 studies initially screened, 8 studies were used in the final analysis with a total of 100 patients who underwent 110 procedures. The most common IVCF was the Greenfield Filter (36%), 60% of patients were males and the mean age was 67.8 years. The overall pooled incidence of acute procedural success was 95.45% (95% confidence interval = 89.54-98.1) with no heterogeneity (I 2 = 0%, p = 1) and there were no reported filter-related complications. Conclusion:This systematic review is the largest study of its kind to demonstrate the safety and feasibility of TFV access in a variety of cardiac procedures in the presence of IVCF.

show abstract

Section: Discussionmentioning

confidence: 99%

Navigating inferior vena cava filters in invasive cardiology procedures: A systematic review

Shah

Patel

Hanson

et al. 2021

Cardiovasc electrophysiol

View full text Add to dashboard Cite

show abstract

“…The use of jugular and hepatic venous access and occluded IVC for delivery of Mitraclip (Abbott, Abbott Park, Illinois) have been reported previously. [1][2][3] To our knowledge, this is the first report of transcatheter mitral valve-in-valve procedure after recanalization of occluded IVC.…”

mentioning

confidence: 83%

Percutaneous Mitral Valve-in-Valve Replacement Through Occluded Inferior Vena Cava

et al. 2022

View full text Add to dashboard Cite

“…MitraClip in postsurgical patients is possible, provided there is suitable tissue for anchoring-a challenge when leaflet resection has been undertaken. Although the DFU for MitraClip excludes its use in patients with femoral or caval thrombi, a case report by Barbin et al shows that it can be done if absolutely necessary and in the context of lack of alternative treatment options (23).…”

Section: Other Applicationsmentioning

confidence: 99%

MitraClip patient selection: inclusion and exclusion criteria for optimal outcomes

Gössl

Sorajja

2018

Ann. Cardiothorac. Surg.

View full text Add to dashboard Cite

Edge-to-edge repair with the percutaneous MitraClip technology has changed the landscape for patients with symptomatic, severe degenerative mitral valve regurgitation who are at prohibitive surgical risk. While the results of randomized controlled trials of MitraClip therapy in patients with functional mitral valve regurgitation are still pending, single center experiences as well as registry data generally support the realworld application of the MitraClip therapy. In the majority of individuals treated with MitraClip, complete or near-complete relief of mitral regurgitation occurs, with results approaching the effectiveness of open surgery. This perspective summarizes the data, with a focus on current selection criteria of percutaneous MitraClip edge-to-edge repair that can optimize clinical outcomes.

show abstract

Successful MitraClip® implantation after angioplasty of a chronic inferior vena cava filter thrombosis

Cited by 4 publications

References 14 publications

Navigating inferior vena cava filters in invasive cardiology procedures: A systematic review

Navigating inferior vena cava filters in invasive cardiology procedures: A systematic review

Percutaneous Mitral Valve-in-Valve Replacement Through Occluded Inferior Vena Cava

MitraClip patient selection: inclusion and exclusion criteria for optimal outcomes

Contact Info

Product

Resources

About